注射用丹参多酚酸对缺血性脑卒中患者hs-CRP水平和血液流变参数的影响(4)
[14] 房阁.注射用丹参多酚酸治疗缺血性脑卒中的临床效果分析[J].中西医结合心脑血管病杂志,2017,15(6):725-727.
[15] 王創畅,吴伟,魏伟超,等.清热,活血中药调控TLR4/MyD88/NF-κB信号干预动脉粥样硬化大鼠模型的实验研究[J].中华中医药学刊,2018,36(3):576-580.
[16] Zhang W,Zhu B,Cao W,et al. Research on the mechanism of drug-drug interaction between salvianolate injection and aspirin based on the metabolic enzyme and PK-PD model:study protocol for a PK-PD trial [J]. Trials,2018,19(1):491.
[17] 梁芳,王翔云,曲华,等.丹参多酚酸盐联合用药治疗冠心病不稳定性心绞痛的系统评价[J].中医药导报,2018, 309(11):108-112.
[18] 白蓉,王淑.注射用丹参多酚酸对脑缺血大鼠VEGF,IL-10的影响[J].中风与神经疾病杂志,2016,33(5):411-416.
[19] 洪序溪.丹参多酚酸盐联合曲美他嗪治疗冠心病心绞痛的效果及安全性[J].中外医学研究,2017,15(35):25-26.
[20] 薛梅苓,冯琴琴.丹参多酚酸盐治疗心血瘀阻型冠心病心绞痛临床疗效及安全性研究[J].中国药业,2016,25(18):31-34.
[21] Liu L,Li J,Zhang Y,et al. Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor:evidence from clinic to laboratory [J]. Thromb Res,2014, 134(4):866-876.
[22] Ma C,Yao Y,Yue QX,et al. Differential proteomic analysis of platelets suggested possible signal cascades network in platelets treated with salvianolic acid B [J]. PLoS One,2011,6(2):e14692.
[23] Huang ZS,Zeng CL,Zhu LJ,et al. Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase [J]. J Thromb Haemost,2010,8(6):1383-1393.
(收稿日期:2019-01-30 本文编辑:封 华), http://www.100md.com(高爱民 王宁 钱倩 刘永刚 任翠剑 齐伟静)
[15] 王創畅,吴伟,魏伟超,等.清热,活血中药调控TLR4/MyD88/NF-κB信号干预动脉粥样硬化大鼠模型的实验研究[J].中华中医药学刊,2018,36(3):576-580.
[16] Zhang W,Zhu B,Cao W,et al. Research on the mechanism of drug-drug interaction between salvianolate injection and aspirin based on the metabolic enzyme and PK-PD model:study protocol for a PK-PD trial [J]. Trials,2018,19(1):491.
[17] 梁芳,王翔云,曲华,等.丹参多酚酸盐联合用药治疗冠心病不稳定性心绞痛的系统评价[J].中医药导报,2018, 309(11):108-112.
[18] 白蓉,王淑.注射用丹参多酚酸对脑缺血大鼠VEGF,IL-10的影响[J].中风与神经疾病杂志,2016,33(5):411-416.
[19] 洪序溪.丹参多酚酸盐联合曲美他嗪治疗冠心病心绞痛的效果及安全性[J].中外医学研究,2017,15(35):25-26.
[20] 薛梅苓,冯琴琴.丹参多酚酸盐治疗心血瘀阻型冠心病心绞痛临床疗效及安全性研究[J].中国药业,2016,25(18):31-34.
[21] Liu L,Li J,Zhang Y,et al. Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor:evidence from clinic to laboratory [J]. Thromb Res,2014, 134(4):866-876.
[22] Ma C,Yao Y,Yue QX,et al. Differential proteomic analysis of platelets suggested possible signal cascades network in platelets treated with salvianolic acid B [J]. PLoS One,2011,6(2):e14692.
[23] Huang ZS,Zeng CL,Zhu LJ,et al. Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase [J]. J Thromb Haemost,2010,8(6):1383-1393.
(收稿日期:2019-01-30 本文编辑:封 华), http://www.100md.com(高爱民 王宁 钱倩 刘永刚 任翠剑 齐伟静)